Trial intelligence / Profile preview

Vinorelbine and Docetaxel Followed by Vinorelbine Maintenance in Advanced Breast Cancer

NCT02144194Phase 2Unknown

Sponsor
Cancer Research Group
Start
Mar 2012
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of vinorelbine in breast cancer, sponsored by Cancer Research Group. Status: unknown.

02

Drugs

vinorelbine
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02144194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02144194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call